|Scooped by Deborah Verran|
Stem cells have been used to try and treat a number of neurological disorders including Parkinsons disease as well as damage to the spinal cord leading to paralysis.
However in what may be currently considered a giant leap of faith a United States biotech company (Bioquark), has gone through the initial stages of seeking regulatory approval for a trial utilizing stem cells to treat patients following the declaration of brain death. The aim is to restore neurological function via a combination of supportive medical treatments along with the injection of stem cells into the spinal cord.
The initial proof of concept study titled the 'Reanima project' will be carried out in India. The study protocol can be viewed via the following link-
More on the story can be viewed by clicking on the following link-
In addition an ethicist asks the question as to whether this planned trial can truly deliver acceptable results-
Deborah Verran's insight:
It seems highly unlikely that any patient in whom a sound diagnosis of brain death has been made, will have their brain function restored to any significant degree via this approach in the near future.